NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
05/13/2024
Back to search
Official data from USPTO
GALECTIN THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
GALECTIN THERAPEUTICS
ST13
US500000085873512Class
5
Filing
85873512
Registration
4476339
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
05/13/2024
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
03/12/2013
Registration date
01/28/2014
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/13/2024
Last transaction
05/13/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
06/28/2013
First use in commerce
06/28/2013
Drawing code
4
Owner type
03
Owner location
Norcross, GA, US
Examiner
BLANE, SUZANNE
Law office
M50
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Galectin Therapeutics Inc.
Representatives
Joseph Agostino GREENBERG TRAURIG, LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparationscompounds for use in the treatment of nonalcoholic steatohepatitisfibrosisinflammatory and autoimmune disordersneoplastic conditionscancerliver fibrosiskidney fibrosislung fibrosis and/or heart fibrosis
Publications
History of USPTO decisions and trademark events.
39 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
05/13/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
05/13/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/13/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
01/26/2024
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01/28/2023
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
02/13/2020
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
02/13/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/12/2020
ES8R
TEAS SECTION 8 RECEIVED
01/03/2020
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/28/2019
CORV
REVIEW OF CORRESPONDENCE COMPLETE - POWER OF ATTORNEY ENTERED
12/03/2018
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
12/03/2018
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
01/28/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
12/20/2013
ALIE
ASSIGNED TO LIE
12/19/2013
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
12/17/2013
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
08/31/2013
IUAA
USE AMENDMENT ACCEPTED
08/30/2013
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
08/21/2013
IUAF
USE AMENDMENT FILED
08/21/2013
EAAU
TEAS AMENDMENT OF USE RECEIVED
08/20/2013
XAEC
EXAMINER'S AMENDMENT ENTERED
08/16/2013
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/16/2013
GNEA
EXAMINERS AMENDMENT E-MAILED
08/16/2013
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/16/2013
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/16/2013
GNRT
NON-FINAL ACTION E-MAILED
08/16/2013
CNRT
NON-FINAL ACTION WRITTEN
08/16/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/16/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/16/2013
ALIE
ASSIGNED TO LIE
07/09/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/03/2013
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/24/2013
GNRT
NON-FINAL ACTION E-MAILED
06/24/2013
CNRT
NON-FINAL ACTION WRITTEN
06/24/2013
DOCK
ASSIGNED TO EXAMINER
06/21/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/18/2013
NWAP
NEW APPLICATION ENTERED
03/15/2013
Continuous trademark protection
Get notified about every new filing that threatens GALECTIN THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.